➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Merck
McKinsey
AstraZeneca
Baxter
Johnson and Johnson

Last Updated: September 24, 2020

DrugPatentWatch Database Preview

Patent: 4,282,070

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 4,282,070
Title: Energy conversion method with water recovery
Abstract:A mechanical energy conversion method and system for the restoration of dissipated heat energy, contained in natural or artificial water bodies at or near ambient temperatures, to industrial process heat, mainly in the form of steam up to 200.degree.-400.degree. C. The sensible heat contained in a water body is concentrated as latent heat in low pressure water vapor which is thermo-compressed by steam ejection to an intermediate pressure level, wherefrom mechanical compression takes over, generating highly superheated output steam. The ejecting steam is not generated in a boiler, but is continuously regenerated by the compressor and routed back for repeated ejection. The compressor is driven by a heat engine whose reject heat is collected and upgraded as well. The output of heat energy is essentially equal to the sum of the heating value of the fuel consumed and the intake of latent heat and amounts thus to substantially more than the heating value of the fuel alone.
Inventor(s): Egosi; Dan (Tel Aviv, IL)
Assignee:
Application Number:05/910,098
Patent Claims:see list of patent claims

Details for Patent 4,282,070

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 001 2006-05-25   Start Trial 2039-09-23 search
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 1 2006-05-25   Start Trial 2039-09-23 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Johnson and Johnson
Boehringer Ingelheim
Colorcon
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.